These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1708534)

  • 1. Interesting times for dopamine receptors.
    Strange PG
    Trends Neurosci; 1991 Feb; 14(2):43-5. PubMed ID: 1708534
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.
    Scharfetter J
    Pharmacogenomics; 2004 Sep; 5(6):691-8. PubMed ID: 15335289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptors and schizophrenia: drug effect or illness?
    Mackay AV; Bird ED; Spokes EG; Rossor M; Iversen LL; Creese I; Snyder SH
    Lancet; 1980 Oct; 2(8200):915-6. PubMed ID: 6107564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia].
    Fog R
    Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative electroencephalographic frequencies and relative neuroleptic receptor affinities in schizophrenia.
    Small JG; Milstein V; Malloy FW; Miller MJ
    Biol Psychiatry; 1996 Jun; 39(11):986-8. PubMed ID: 9162214
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of action of anti-psychotic drugs.
    Strange PG
    Biochem Soc Trans; 1999 Feb; 27(2):175-8. PubMed ID: 10093729
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 13. 1-Phenyl-3-(aminomethyl)pyrroles as potential antipsychotic agents. Synthesis and dopamine receptor binding.
    Thurkauf A; Yuan J; Chen X; Wasley JW; Meade R; Woodruff KH; Huston K; Ross PC
    J Med Chem; 1995 Dec; 38(25):4950-2. PubMed ID: 8523409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptors in substantia nigra in schizophrenia.
    Owen R; Owen F; Poulter M; Crow TJ
    Brain Res; 1984 May; 299(1):152-4. PubMed ID: 6144367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereospecificity and clinical potency of neuroleptics.
    Crow TJ; Deakin JW; Johnstone EC
    Nature; 1977 May; 267(5607):183-4; author reply 184. PubMed ID: 16073446
    [No Abstract]   [Full Text] [Related]  

  • 20. Schizophrenia and dopamine receptors.
    Seeman P
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):999-1009. PubMed ID: 23860356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.